These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 12584031

  • 1. Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate.
    Montagnani A, Gonnelli S, Cepollaro C, Campagna MS, Franci MB, Pacini S, Gennari C.
    Bone; 2003 Jan; 32(1):15-9. PubMed ID: 12584031
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study.
    Gutteridge DH, Retallack RW, Ward LC, Stuckey BG, Stewart GO, Prince RL, Kent GN, Bhagat CI, Price RI, Thompson RI, Nicholson GC.
    Bone; 1996 Oct; 19(4):387-94. PubMed ID: 8894145
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Wimalawansa SJ, Gunasekera RD.
    Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels.
    Ang G, Feiglin D, Moses AM.
    Endocr Pract; 2003 Oct; 9(4):280-3. PubMed ID: 14561571
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone.
    Merlotti D, Gennari L, Martini G, Valleggi F, De Paola V, Avanzati A, Nuti R.
    J Bone Miner Res; 2007 Oct; 22(10):1510-7. PubMed ID: 17605632
    [Abstract] [Full Text] [Related]

  • 12. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.
    Thiébaud D, Jaeger P, Gobelet C, Jacquet AF, Burckhardt P.
    Am J Med; 1988 Aug; 85(2):207-12. PubMed ID: 3261129
    [Abstract] [Full Text] [Related]

  • 13. High-dose pamidronate in the management of resistant Paget's disease.
    Cundy T, Wattie D, King AR.
    Calcif Tissue Int; 1996 Jan; 58(1):6-8. PubMed ID: 8825232
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium.
    Stewart GO, Gutteridge DH, Price RI, Ward L, Retallack RW, Prince RL, Stuckey BG, Kent GN, Bhagat CI, Dhaliwal SS.
    Bone; 1999 Feb; 24(2):139-44. PubMed ID: 9951784
    [Abstract] [Full Text] [Related]

  • 19. [Bisphosphonate therapy of Paget's disease of bone with pamidronate].
    Grauer A, Klar B, Knaus J, Scharla SH, Ziegler R.
    Med Klin (Munich); 1996 Jan 15; 91(1):14-9. PubMed ID: 8839196
    [Abstract] [Full Text] [Related]

  • 20. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE.
    Arch Intern Med; 1989 Dec 15; 149(12):2765-7. PubMed ID: 2596945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.